Carmen Cascales

Title: Carmen Cascales: Innovator in Farnesyl-Protein Transferase Inhibition

Introduction

Carmen Cascales is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit farnesyl-protein transferase (FPTase). Her work is crucial in the fight against cancer, as it targets the oncogene protein Ras, which is often implicated in tumor growth.

Latest Patents

Carmen holds a patent for her invention titled "Inhibitors of Farnesyl-Protein Transferase." This patent describes non-peptide compounds that effectively inhibit FPTase and the farnesylation process of the oncogene protein Ras. The invention also outlines a method for preparing these compounds through the cultivation of a culture of Phoma sp. Additionally, it includes chemotherapeutic compositions that utilize these compounds and methods for their application in cancer treatment.

Career Highlights

Carmen Cascales is currently associated with Merck & Co., Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in cancer therapies.

Collaborations

Carmen has collaborated with notable colleagues, including Russell B Lingham and Fernando Pelaez. These partnerships have enhanced her research and expanded the impact of her inventions in the scientific community.

Conclusion

Carmen Cascales is a trailblazer in the field of biochemistry, with her patent on farnesyl-protein transferase inhibitors representing a significant advancement in cancer treatment. Her contributions continue to inspire future innovations in the pharmaceutical industry.